Trial Profile
Study of ARN2966 in Alzheimer's disease
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 14 Jul 2016
Price :
$35
*
At a glance
- Drugs ARN 2966 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 14 Jul 2016 New trial record